LifeVantage Appoints Raymond Greer as Chairman of the Board of Directors
November 27 2023 - 4:05PM
LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the
“Company”), a leading health and wellness company with products
designed to activate optimal health processes, today announced that
the Board of Directors has appointed Raymond Greer as Chairman of
the Board. He succeeds Garry Mauro, who will continue to serve as a
member of the Board of Directors.
“We want to thank Garry for his many
contributions while serving as Chairman. He provided critical
leadership around our efforts to revamp the management team over
the past several years and helped to shape our comprehensive
strategic LV360 transformation,” said Steve Fife, President and
Chief Executive Officer of LifeVantage.
Mr. Mauro commented, “It’s been an honor to
serve as Chairman of the Board at LifeVantage. The steps we have
taken to reenergize growth and improve profitability are gaining
traction and put us in a strong position to deliver significant
value in the future.”
Mr. Fife added, “The appointment of Raymond
Greer as Chairman provides continuity along with strong leadership.
Mr. Greer has been an independent director of LifeVantage since
2017 and has a deep understanding of our business. He is an
accomplished executive and proven leader with over 35 years of
experience encompassing global operations and technology.”
Mr. Greer said, “It is a privilege to have been
chosen to serve as Chairman by my fellow directors. Our diverse,
experienced and independent Board provides perspective and
direction to support management along with effective oversight to
ensure we are optimizing value for all stakeholders. LifeVantage
has significant business momentum and I’m thrilled to take on this
expanded role at such an exciting time.”
About LifeVantage
Corporation
LifeVantage Corporation (Nasdaq: LFVN), the
activation company, is a pioneer in nutrigenomics, the study of how
nutrition and naturally occurring compounds affect human genes to
support good health. The Company engages in the identification,
research, development, formulation and sale of advanced
nutrigenomic activators, dietary supplements, nootropics, pre- and
pro-biotics, weight management, skin and hair care, bath &
body, and targeted relief products. The Company’s line of
scientifically-validated dietary supplements includes its flagship
Protandim® family of products, LifeVantage® Omega+, ProBio, IC
Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary
supplements, the TrueScience® line of skin, hair, bath & body,
and targeted relief products. The Company also markets and sells
Petandim®, its companion pet supplement formulated to combat
oxidative stress in dogs, Axio® its nootropic energy drink mixes,
and PhysIQ, its smart weight management system. LifeVantage was
founded in 2003 and is headquartered in Lehi, Utah. For more
information, visit www.lifevantage.com.
Cautionary Note Regarding Forward
Looking Statements
This document contains forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words and
expressions reflecting optimism, satisfaction or disappointment
with current prospects, as well as words such as “believe,” “will,”
“hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,”
“anticipates,” “look forward to,” “goal,” “may be,” and variations
thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. The
declaration and/or payment of a dividend during any quarter
provides no assurance as to future dividends, and the timing and
amount of future dividends, if any, could vary significantly in
comparison both to past dividends and to current expectations.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding executing against and the benefits
of our key initiatives, future growth, including geographic and
product expansion, the impact of COVID-19 on our business, expected
financial performance, and expected dividend payments in future
quarters. Such forward-looking statements are not guarantees of
performance and the Company’s actual results could differ
materially from those contained in such statements. These
forward-looking statements are based on the Company’s current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company’s actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, further deterioration to
the global economic and operating environments as a result of
future COVID-19 developments, as well as those discussed in greater
detail in the Company’s Annual Report on Form 10-K and the
Company’s Quarterly Report on Form 10-Q under the caption “Risk
Factors,” and in other documents filed by the Company from time to
time with the U.S. Securities and Exchange Commission (the “SEC”).
The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR(646)
277-1260reed.anderson@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2024 to May 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From May 2023 to May 2024